CASI PHARMACEUTICALS, INC. Income Tax Expense
CASI PHARMACEUTICALS, INC. (CASIF) reported Income Tax Expense of $0 for the 12-month period ending 2024-12-31, per its 20-F filed 2025-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-05-15
| Period end | Income Tax Expense (Benefit) 12 month |
|---|---|
| 2024-12-31 | $0.00 20-F · filed 2025-03-31 |
| 2023-12-31 | -$81.00K 20-F · filed 2026-05-15 |
| 2022-12-31 | $1.98M 20-F · filed 2025-03-31 |
| 2021-12-31 | $0.00 20-F · filed 2024-03-28 |
| 2020-12-31 | $0.00 20-F · filed 2023-04-26 |